Patient Enrollment Completed for Clinical Trial of Peijia Medical’s Shenyi® Stent Retriever-Brief News on Innovation-

You are about to leave Peijia Medical's official Chinese website.

You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.

Cancel

Continue

Company News Brief News on Innovation

Patient Enrollment Completed for Clinical Trial of Peijia Medical’s Shenyi® Stent Retriever

2021-02-01 16:56:03

On February 1, 2021, Peijia Medical announced that patient enrollment for clinical trial of Shenyi^® Stent Retriever had been successfully completed as of January 29, 2021. Shenyi^® Stent Retriever is a major product under development from the Company’s neurointerventional product line.

Shenyi^® Stent Retriever is used for removing fresh thrombus in intracranial vessels in a mechanical thrombectomy procedure for patients with acute ischemic stroke. As soon as all the preparations have been made, the Company plans to submit a registration application to National Medical Products Administration (NMPA)

Prev：Peijia Medical Successfully Commenced Animal Study for its Mitral Valve Edge-to-Edge Repair Product

Next：Peijia Medical’s TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercializa